177 related articles for article (PubMed ID: 18829738)
1. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress.
Hagiwara M; Bledsoe G; Yang ZR; Smith RS; Chao L; Chao J
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1735-43. PubMed ID: 18829738
[TBL] [Abstract][Full Text] [Related]
2. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
Zhou YB; Sun HJ; Chen D; Liu TY; Han Y; Wang JJ; Tang CS; Kang YM; Zhu GQ
Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
[TBL] [Abstract][Full Text] [Related]
3. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.
Liu Y; Bledsoe G; Hagiwara M; Shen B; Chao L; Chao J
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1230-8. PubMed ID: 22811485
[TBL] [Abstract][Full Text] [Related]
4. Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress.
Qiao X; Li RS; Li H; Zhu GZ; Huang XG; Shao S; Bai B
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F112-9. PubMed ID: 23077098
[TBL] [Abstract][Full Text] [Related]
5. Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation.
Wang Y; Tian J; Guo H; Mi Y; Zhang R; Li R
Clin Exp Med; 2016 May; 16(2):183-92. PubMed ID: 25916508
[TBL] [Abstract][Full Text] [Related]
6. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
[TBL] [Abstract][Full Text] [Related]
7. The protective role of intermedin in promoting angiogenesis during renal fibrosis.
Dong H; Zhou Y; Wang Y; Zhou Q; Zhang Y; Gan X; Luo Y; Li R
Gene; 2019 Mar; 688():34-43. PubMed ID: 30472381
[TBL] [Abstract][Full Text] [Related]
8. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
[TBL] [Abstract][Full Text] [Related]
9. Intermedin is a new angiogenic growth factor.
Smith RS; Gao L; Bledsoe G; Chao L; Chao J
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1040-7. PubMed ID: 19592612
[TBL] [Abstract][Full Text] [Related]
10. Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression.
Wang Y; Li R; Qiao X; Tian J; Su X; Wu R; Zhang R; Zhou X; Li J; Shao S
Nephrology (Carlton); 2013 Sep; 18(9):623-32. PubMed ID: 23782291
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion.
Zhao L; Peng DQ; Zhang J; Song JQ; Teng X; Yu YR; Tang CS; Qi YF
Peptides; 2012 Feb; 33(2):329-35. PubMed ID: 22244813
[TBL] [Abstract][Full Text] [Related]
12. Intermedin attenuates renal fibrosis by induction of heme oxygenase-1 in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Su X; Qiao Y; Fan Y; Peng Z
BMC Nephrol; 2017 Jul; 18(1):232. PubMed ID: 28697727
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.
Jolly L; March JE; Kemp PA; Bennett T; Gardiner SM
Br J Pharmacol; 2009 Aug; 157(8):1502-13. PubMed ID: 19681873
[TBL] [Abstract][Full Text] [Related]
14. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake.
Taylor MM; Bagley SL; Samson WK
Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R919-27. PubMed ID: 15576658
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia Up-Regulates the Expression of Intermedin and Its Receptor Components in the Aorta of Rats via Inducing the Oxidative Stress.
Meng Q; Shi D; Feng J; Su Y; Long Y; He S; Wang S; Wang Y; Zhang X; Chen X
Ann Clin Lab Sci; 2016; 46(1):5-17. PubMed ID: 26927337
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
17. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
Shen B; Hagiwara M; Yao YY; Chao L; Chao J
Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency.
Bell D; Zhao Y; McCoy FP; Devine AB; McDermott BJ
Cell Physiol Biochem; 2007; 20(5):269-82. PubMed ID: 17762156
[TBL] [Abstract][Full Text] [Related]
19. Intermedin (adrenomedullin-2): a potential protective role in human aortic endothelial cells.
Pearson LJ; Yandle TG; Nicholls MG; Evans JJ
Cell Physiol Biochem; 2009; 23(1-3):97-108. PubMed ID: 19255504
[TBL] [Abstract][Full Text] [Related]
20. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure.
Hirose T; Totsune K; Mori N; Mori T; Morimoto R; Metoki H; Asayama K; Kikuya M; Ohkubo T; Kohzuki M; Takahashi K; Imai Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F128-34. PubMed ID: 20462970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]